HighVia—A Flexible Live-Cell High-Content Screening Pipeline to Assess Cellular Toxicity

The good, the bad and the autophagosome: exploring unanswered questions of autophagy-dependent cell death

(2019) Jurgen Kriel et al.   CELL DEATH AND DIFFERENTIATION

Progress towards a public chemogenomic set for protein kinases and a call for contributions

(2017) David H. Drewry et al.   PLoS One

Combining High-Content Imaging and Phenotypic Classification Analysis of Senescence-Associated Beta-Galactosidase Staining to Identify Regulators of Oncogene-Induced Senescence

(2016) Keefe T. Chan et al.   ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES

Cell Painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes

(2016) Mark-Anthony Bray et al.   Nature Protocols

Microscopy-Based High-Content Screening

(2015) Michael Boutros et al.   CELL

Academic drug discovery within the United Kingdom: a reassessment

(2015) Emma Shanks et al.   NATURE REVIEWS DRUG DISCOVERY

Cell-Size Control

(2015) Amanda A. Amodeo et al.   Cold Spring Harbor Perspectives in Biology

Alamar blue reagent interacts with cell-culture media giving different fluorescence over time: Potential for false positives

(2014) Soumyabrata Munshi et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

Considerations regarding use of solvents in in vitro cell based assays

(2013) Michael Timm et al.   CYTOTECHNOLOGY

Phenotypic screens as a renewed approach for drug discovery

(2013) Wei Zheng et al.   DRUG DISCOVERY TODAY

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

US academic drug discovery

(2011) Stephen Frye et al.   NATURE REVIEWS DRUG DISCOVERY